Company Filing History:
Years Active: 2008-2012
Title: The Innovations of Peter Bohlen
Introduction
Peter Bohlen is a notable inventor based in New York, NY, with a focus on advancements in biotechnology. He holds three patents that contribute significantly to the field of medical science, particularly in the development of monoclonal antibodies.
Latest Patents
His latest patents include innovative antibodies against vascular endothelial growth factor receptor-1 (VEGFR-1). These monoclonal antibodies are specifically designed to target VEGFR-1, providing nucleotide sequences that encode and amino acid sequences comprising variable heavy and light chain immunoglobulin molecules. This invention also details the complementarity determining regions of CDR1, CDR2, and CDR3. Furthermore, it outlines methods for generating and expressing anti-VEGFR-1 antibodies, as well as therapeutic approaches for treating angiogenic-related disorders and reducing tumor growth through the administration of these antibodies.
Career Highlights
Throughout his career, Peter Bohlen has made significant contributions while working with prominent companies such as Imclone LLC and Imclone Systems, Inc. His work has been pivotal in advancing the understanding and treatment of various medical conditions.
Collaborations
Peter has collaborated with notable colleagues, including Yan Wu and Daniel J Hicklin, enhancing the impact of his research and innovations.
Conclusion
Peter Bohlen's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of treatments for critical health issues.